Watch the on-demand session.
Learn from Dr. Ceri Wiggins and Dr. Angelos Papadopoulos from AstraZeneca as they share how arrayed CRISPR screens can be scaled to tackle the complexity of immune target discovery.
Presented at EditCo Draughts & Discoveries 2026 in Cambridge, UK, this session highlights how advanced screening strategies enable more precise interrogation of immune pathways, improving target identification and accelerating translational research.
Struggling to scale your CRISPR screens for immune targets?